PMID- 29690626 OWN - NLM STAT- MEDLINE DCOM- 20180924 LR - 20181114 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 10 IP - 4 DP - 2018 Apr 23 TI - Effects of Chlorogenic Acid-Enriched and Hydroxyhydroquinone-Reduced Coffee on Postprandial Fat Oxidation and Antioxidative Capacity in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. LID - 10.3390/nu10040525 [doi] LID - 525 AB - Chlorogenic acids (CGAs) reduce blood pressure and body fat, and enhance fat metabolism. In roasted coffee, CGAs exist together with the oxidant component hydroxyhydroquinone (HHQ). HHQ counteracts the antihypertensive effects of CGA, but its effects on CGA-induced fat oxidation (FOX) are unknown. Here we assessed the effects of CGA-enriched and HHQ-reduced coffee on FOX. Fifteen healthy male volunteers (age: 38 ± 8 years (mean ± SD); BMI: 22.4 ± 1.5 kg/m(2)) participated in this crossover study. Subjects consumed the test beverage (coffee) containing the same amount of CGA with HHQ (CGA-HHQ(+)) or without HHQ (CGA-HHQ(−)) for four weeks. Postprandial FOX and the ratio of the biological antioxidant potential (BAP) to the derivatives of reactive oxygen metabolites (d-ROMs) as an indicator of oxidative stress were assessed. After the four-week intervention, postprandial FOX and the postprandial BAP/d-ROMs ratio were significantly higher in the CGA-HHQ(−) group compared with the CGA-HHQ(+) group (4 ± 23 mg/min, group effect: p = 0.040; 0.27 ± 0.74, group effect: p = 0.007, respectively). In conclusion, reducing the amount of HHQ facilitated the postprandial FOX effects of CGA in coffee. Our findings also suggest that the mechanism underlying the inhibition of FOX by HHQ is related to postprandial oxidative stress. FAU - Katada, Shun AU - Katada S AD - Biological Science Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. katada.shun@kao.com. FAU - Watanabe, Takuya AU - Watanabe T AD - Biological Science Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. watanabe.takuya@kao.com. FAU - Mizuno, Tomohito AU - Mizuno T AD - Biological Science Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. mizuno.tomohito@kao.com. FAU - Kobayashi, Shinichi AU - Kobayashi S AD - Health Care Food Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. kobayashi.shinichi@kao.com. FAU - Takeshita, Masao AU - Takeshita M AD - Health Care Food Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. takeshita.masao@kao.com. FAU - Osaki, Noriko AU - Osaki N AD - Biological Science Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. osaki.noriko@kao.com. FAU - Kobayashi, Shigeru AU - Kobayashi S AD - Department of Surgery, Tokyo Rinkai Hospital, 1-4-2 Rinkai-cho, Edogawa, Tokyo 134-0086, Japan. kobayashi.shigeru1@kao.com. FAU - Katsuragi, Yoshihisa AU - Katsuragi Y AD - Health Care Food Research Laboratories, Kao Corporation, 2-1-3 Bunka, Sumida, Tokyo 131-8501, Japan. katsuragi.yoshihisa@kao.com. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20180423 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 RN - 0 (Antioxidants) RN - 0 (Coffee) RN - 0 (Hydroquinones) RN - 0 (Reactive Oxygen Species) RN - 173O8B04RD (hydroxyhydroquinone) RN - 318ADP12RI (Chlorogenic Acid) SB - IM MH - Adult MH - Antioxidants/*administration & dosage/adverse effects/analysis MH - Chlorogenic Acid/*administration & dosage/adverse effects/analysis MH - Coffee/adverse effects/*chemistry MH - Cross-Over Studies MH - Double-Blind Method MH - Healthy Volunteers MH - Humans MH - Hydroquinones/*analysis MH - Lipid Metabolism/*drug effects MH - Male MH - *Men's Health MH - Middle Aged MH - Oxidation-Reduction MH - Oxidative Stress/drug effects MH - *Postprandial Period MH - Reactive Oxygen Species/blood MH - Tokyo PMC - PMC5946310 OTO - NOTNLM OT - chlorogenic acids OT - fat oxidation OT - hydroxyhydroquinone OT - oxidative stress COIS- The authors declare no conflicts of interest. This work was financed by Kao Corporation and no external funding was received. EDAT- 2018/04/25 06:00 MHDA- 2018/09/25 06:00 PMCR- 2018/04/01 CRDT- 2018/04/26 06:00 PHST- 2018/03/27 00:00 [received] PHST- 2018/04/12 00:00 [revised] PHST- 2018/04/18 00:00 [accepted] PHST- 2018/04/26 06:00 [entrez] PHST- 2018/04/25 06:00 [pubmed] PHST- 2018/09/25 06:00 [medline] PHST- 2018/04/01 00:00 [pmc-release] AID - nu10040525 [pii] AID - nutrients-10-00525 [pii] AID - 10.3390/nu10040525 [doi] PST - epublish SO - Nutrients. 2018 Apr 23;10(4):525. doi: 10.3390/nu10040525.